Inhibition of the neutrophil oxidative response to a chemotactic peptide by inhibitors of arachidonic acid oxygenation.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology*; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D001095:Arachidonic Acids / Q000378:metabolism*; D001241:Aspirin / Q000378:metabolism*; D002633:Chemotaxis / Q000187:drug effects; D003571:Cytochalasin B / Q000494:pharmacology*; D004072:Digitonin / Q000494:pharmacology*; D004151:Dipeptides / Q000494:pharmacology*; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D006168:Guinea Pigs; D007213:Indomethacin / Q000494:pharmacology*; D007700:Kinetics; D008715:Methionine / Q000031:analogs & derivatives*; D009239:N-Formylmethionine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D010101:Oxygen Consumption / Q000187:drug effects*
D001095:Arachidonic Acids; D004151:Dipeptides; D005231:Fatty Acids, Unsaturated; D015117:5,8,11,14-Eicosatetraynoic Acid; D003571:Cytochalasin B; D009239:N-Formylmethionine; D000968:Antimycin A; D008715:Methionine; D004072:Digitonin; D001241:Aspirin; D007213:Indomethacin